Beth Hecht - Net Worth and Insider Trading
Beth Hecht Net Worth
The estimated net worth of Beth Hecht is at least $9 Million dollars as of 2026-09-11. Beth Hecht is the See Remarks of Xeris Biopharma Holdings Inc and owns about 1,127,796 shares of Xeris Biopharma Holdings Inc (XERS) stock worth over $9 Million. Details can be seen in Beth Hecht's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Beth Hecht has not made any transactions after 2026-09-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Beth Hecht
Beth Hecht Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Beth Hecht owns 4 companies in total, including Xeris Biopharma Holdings Inc (XERS) , Neos Therapeutics Inc (NEOS) , and Aytu BioPharma Inc (AYTU) among others .
Click here to see the complete history of Beth Hecht’s form 4 insider trades.
Insider Ownership Summary of Beth Hecht
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| XERS | Xeris Biopharma Holdings Inc | 2026-09-01 | See Remarks |
| NEOS | Neos Therapeutics Inc | 2020-06-10 | director |
| AYTU | Aytu BioPharma Inc | 2021-03-19 | director |
 | | 2021-03-18 | director |
Beth Hecht Latest Holdings Summary
Beth Hecht currently owns a total of 1 stock. Beth Hecht owns 1,127,796 shares of Xeris Biopharma Holdings Inc (XERS) as of September 1, 2026, with a value of $9 Million.
Latest Holdings of Beth Hecht
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings Inc | 2026-09-01 | 1,127,796 | 7.66 | 8,638,917 |
Holding Weightings of Beth Hecht
Beth Hecht Form 4 Trading Tracker
According to the SEC Form 4 filings, Beth Hecht has made a total of 12 transactions in Xeris Biopharma Holdings Inc (XERS) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Xeris Biopharma Holdings Inc is the sale of 16,666 shares on September 1, 2026, which brought Beth Hecht around $141,494.
Insider Trading History of Beth Hecht
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Beth Hecht Trading Performance
GuruFocus tracks the stock performance after each of Beth Hecht's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Beth Hecht is 36.91%. GuruFocus also compares Beth Hecht's trading performance to market benchmark return within the same time period. The performance of stocks bought by Beth Hecht within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Beth Hecht's insider trading performs compared to the benchmark.
Performance of Beth Hecht
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -19.39 | | | | | |
| Relative Return to S&P 500(%) | -14.04 | | | | | |
Beth Hecht Ownership Network
Ownership Network List of Beth Hecht
Ownership Network Relation of Beth Hecht
Beth Hecht Owned Company Details
What does Xeris Biopharma Holdings Inc do?
Who are the key executives at Xeris Biopharma Holdings Inc?
Beth Hecht is the See Remarks of Xeris Biopharma Holdings Inc. Other key executives at Xeris Biopharma Holdings Inc include See Remarks Kevin Mcculloch , Chief Financial Officer Steven Pieper , and See Remarks Shannon John Patrick Jr .
Xeris Biopharma Holdings Inc (XERS) Insider Trades Summary
Over the past 18 months, Beth Hecht made 12 insider transaction in Xeris Biopharma Holdings Inc (XERS) with a net sale of 223,334. Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net sale of 110,000 shares made by Kevin Mcculloch , a net sale of 257,900 shares made by John Johnson , and a net sale of 55,000 shares made by Steven Pieper .
In summary, during the past 3 months, insiders sold 224,998 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 0 shares, with a net sale of 224,998 shares. During the past 18 months, 896,949 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 871,949 shares.
Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xeris Biopharma Holdings Inc Insider Transactions
Beth Hecht Mailing Address
Above is the net worth, insider trading, and ownership report for Beth Hecht. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Beth Hecht's mailing address is: Grand Prairie Tx 75050.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
